Profil
David A. Spellman formerly worked at Vertex Pharmaceuticals, Inc., as VP-Commercial & International Finance, Mersana Therapeutics, Inc., as Chief Financial Officer from 2018 to 2019, Intarcia Therapeutics, Inc., as Chief Financial & Business Officer from 2019 to 2020, and Akebia Therapeutics, Inc., as Treasurer, Chief Financial & Accounting Officer from 2022 to 2023.
Mr. Spellman received his undergraduate degree from The Wharton School of the University of Pennsylvania.
Anciens postes connus de David Spellman
| Sociétés | Poste | Fin |
|---|---|---|
| AKEBIA THERAPEUTICS, INC. | Directeur Financier/CFO | 23/06/2023 |
Intarcia Therapeutics, Inc.
Intarcia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops innovative therapies utilizing the Medici drug delivery system | Directeur Financier/CFO | 29/06/2020 |
| MERSANA THERAPEUTICS | Directeur Financier/CFO | 30/06/2019 |
| VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | - |
Formation de David Spellman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Vertex Pharmaceuticals, Inc.
Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Mersana Therapeutics, Inc.
Mersana Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures antibody drug conjugates to improve patient outcomes in multiple oncology indications | Health Technology |
Intarcia Therapeutics, Inc.
Intarcia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops innovative therapies utilizing the Medici drug delivery system | Health Technology |
Akebia Therapeutics, Inc.
Akebia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for kidney diseases | Health Technology |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















